News Sentiment

GH sentiment intelligence

Guardant Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 160.05 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-4.7% over one week, +21.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

How Expanded Coverage for Guardant’s Shield Test Will Impact UnitedHealth Group (UNH) Investors

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -4.7% Price reacting lower
Trend fit Trend active 21.6% over four weeks
Fair value 208.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 34
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Simply Wall Street 6
Market source 6
simplywall.st 6
TradingView 4
Investing.com 4
Moomoo 3
GuruFocus 1

Event Lens

What the news is about

Classified themes
Market update 29
Analyst action 10
Earnings 8
Deals and strategy 2
Regulatory and legal 2
Balance sheet 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
MedTech Dive Direct company coverage

Guardant’s Shield colon cancer blood test snags UnitedHealth coverage

Guardant Health's Shield test for colorectal cancer has secured coverage from UnitedHealth, marking the first time a major private U.S. health insurer will reimburse for the screening. This decision expands access to approximately 100 million Americans and is considered a "waters

Tone
Positive 82/100
Event
Market update
Published
02 Jul 2026 16:12
Source
MedTech Dive
Investing.com Direct company coverage

Bernstein raises Guardant Health stock price target on UnitedHealth coverage

Bernstein SocGen Group increased its price target for Guardant Health (NASDAQ:GH) shares to $200 from $175, maintaining an Outperform rating. This follows UnitedHealth Group's decision to cover Guardant Health's Shield colorectal cancer screening test, a move expected to signific

Tone
Positive 76/100
Event
Analyst action
Published
02 Jul 2026 16:12
Source
Investing.com
Stock Titan Direct company coverage

Guardant Health (GH) files to resell 4,000 shares via cashless option exercise

Guardant Health (GH) has filed a Form 144 to resell 4,000 shares of common stock through a cashless employee option exercise on July 1, 2026. The filing also details recent open-market sales by Meghan V. Joyce in June 2026, totaling 20,203 shares across multiple transactions. The

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 20:40
Source
Stock Titan
StocksToTrade Direct company coverage

Guardant Health Stock Climbs As Wall Street Targets Surge

Guardant Health (GH) stock surged after the FDA cleared its Guardant360 CDx as a companion test for a new HER2-mutant lung cancer drug, boosting investor optimism. Major Wall Street banks, including RBC Capital and Evercore ISI, initiated or upgraded coverage with significantly h

Tone
Positive 72/100
Event
Market update
Published
01 Jul 2026 19:40
Source
StocksToTrade